TABLE 3.
Statutory health insurance (SHI) costs associated with oral corticosteroid (OCS) therapy for asthma in the sample (2015) rounded to full €
| (% of total costs) total | Cost per patient mean±sd | Extrapolation to SHI | Extrapolation to the German population | |
| Inpatient costs | ||||
| No OCSs | 24 275 598 | 1439±4503 | 433 420 485 | 497 577 478 |
| OCS total | (41.6) 25 169 611 | 2953±8130 | 449 382 345 | 515 902 089 |
| Infrequent short-term | 5 584 650 | 1824±6208 | 99 709 247 | 114 468 691 |
| Frequent short-term | 1 917 646 | 2053±4676 | 34 237 959 | 39 306 027 |
| Long-term >20 to ≤90 days | 5 171 143 | 2764±8572 | 92 326 439 | 105 993 045 |
| Long-term >90 to ≤180 days | 4 764 609 | 4024±8234 | 85 068 115 | 97 660 308 |
| Long-term >180 days | 7 731 563 | 5245±11 465 | 138 040 585 | 158 474 019 |
| Outpatient costs | ||||
| No OCSs | 16 372 180 | 971±835 | 292 311 574 | 335 580 945 |
| OCS total | (17.1) 10 335 019 | 1212±955 | 184 523 120 | 211 837 123 |
| Infrequent short-term | 3 486 655 | 1139±899 | 62 251 306 | 71 466 045 |
| Frequent short-term | 1 085 762 | 1162±874 | 19 385 367 | 22 254 882 |
| Long-term >20 to ≤90 days | 2 271 890 | 1214±962 | 40 562 686 | 46 566 971 |
| Long-term >90 to ≤180 days | 1 512 427 | 1277±1096 | 27 003 116 | 31 000 248 |
| Long-term >180 days | 1 978 286 | 1342±971 | 35 320 645 | 40 548 977 |
| Medication costs | ||||
| No OCSs | 24 788 284 | 1469±3549 | 442 574 076 | 508 086 027 |
| OCS total | (32.4) 19 612 646 | 2301±6884 | 350 167 375 | 402 000 840 |
| Infrequent short-term | 5 126 605 | 1675±3550 | 91 531 236 | 105 080 132 |
| Frequent short-term | 1 554 272 | 1664±2576 | 27 750 222 | 31 857 943 |
| Long-term >20 to ≤90 days | 4 016 750 | 2147±5261 | 71 715 702 | 82 331 407 |
| Long-term >90 to ≤80 days | 3 414 204 | 2884±7136 | 60 957 754 | 69 981 016 |
| Long-term >180 days | 5 500 816 | 3732±12 821 | 98 212 460 | 112 750 343 |
| Costs for remedies and aids | ||||
| No OCSs | 5 211 548 | 309±1147 | 93 047 822 | 106 821 210 |
| OCS total | (7.4) 4 459 583 | 523±2009 | 79 622 124 | 91 408 175 |
| Infrequent short-term | 1 081 684 | 353±957 | 19 312 558 | 22 171 296 |
| Frequent short-term | 363 416 | 389±1200 | 6 488 495 | 7 448 954 |
| Long-term >20 to ≤90 days | 844 355 | 451±1816 | 15 075 249 | 17 306 760 |
| Long-term >90 to ≤180 days | 931 294 | 787±3751 | 16 627 480 | 19 088 760 |
| Long-term >180 days | 1 238 834 | 840±2192 | 22 118 342 | 25 392 406 |
| Sickness benefits | ||||
| No OCSs | 1 323 779 | 78±803 | 23 634 960 | 27 133 521 |
| OCS total | (1.4) 865 275 | 102±925 | 15 448 767 | 17 735 568 |
| Infrequent short-term | 319 927 | 105±1034 | 5 712 024 | 6 557 545 |
| Frequent short-term | 76 770 | 82±656 | 1 370 667 | 1 573 560 |
| Long-term >20 to ≤90 days | 167 263 | 89±822 | 2 986 344 | 3 428 398 |
| Long-term >90 to ≤180 days | 163 908 | 138±1091 | 2 926 434 | 3 359 619 |
| Long-term >180 days | 137 408 | 93±803 | 2 453 297 | 2 816 446 |
| Total costs | ||||
| No OCSs | 71 971 388 | 4266±6690 | 1 284 988 917 | 1 475 199 180 |
| OCS total | (100) 60 442 134 | 7091±12 115 | 1 079 143 731 | 1 238 883 795 |
| Infrequent short-term | 15 599 520 | 5096±8206 | 278 516 370 | 319 743 708 |
| Frequent short-term | 4 997 866 | 5351±6670 | 89 232 710 | 102 441 367 |
| Long-term >20 to ≤90 days | 12 471 401 | 6666±11 897 | 222 666 422 | 255 626 581 |
| Long-term >90 to ≤180 days | 10 786 442 | 9110±12 785 | 192 582 900 | 221 089 950 |
| Long-term >180 days | 16 586 906 | 11 253±18 418 | 296 145 329 | 339 982 190 |